Transcat, Inc. $TRNS Stock Sold by Royce & Associates LP

Royce & Associates LP lessened its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 21.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 339,995 shares of the scientific and technical instruments company’s stock after selling 91,676 shares during the quarter. Royce & Associates LP owned 3.62% of Transcat worth $30,062,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Russell Investments Group Ltd. increased its position in shares of Transcat by 41.8% during the third quarter. Russell Investments Group Ltd. now owns 24,929 shares of the scientific and technical instruments company’s stock valued at $2,204,000 after acquiring an additional 7,348 shares during the last quarter. R Squared Ltd acquired a new position in shares of Transcat in the 3rd quarter worth approximately $274,000. Riverbridge Partners LLC lifted its holdings in shares of Transcat by 8.4% in the 3rd quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock worth $19,404,000 after acquiring an additional 17,063 shares during the last quarter. Summit Creek Advisors LLC boosted its position in shares of Transcat by 23.8% during the 3rd quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock worth $5,140,000 after purchasing an additional 11,165 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Transcat during the 3rd quarter worth approximately $221,000. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Down 2.1%

Transcat stock traded down $2.25 during mid-day trading on Friday, reaching $104.08. 91,195 shares of the company’s stock were exchanged, compared to its average volume of 203,565. The company has a market cap of $978.87 million, a P/E ratio of 216.84 and a beta of 0.61. Transcat, Inc. has a twelve month low of $50.23 and a twelve month high of $112.44. The company has a quick ratio of 2.19, a current ratio of 2.57 and a debt-to-equity ratio of 0.38. The company has a fifty day moving average of $89.01 and a 200-day moving average of $83.53.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.45 by $0.19. Transcat had a net margin of 1.26% and a return on equity of 6.14%. The company had revenue of $97.09 million during the quarter, compared to analysts’ expectations of $92.46 million. Sell-side analysts expect that Transcat, Inc. will post 2.06 EPS for the current year.

Analyst Ratings Changes

A number of analysts have issued reports on TRNS shares. Zacks Research raised Transcat from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 5th. Oppenheimer upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 price target for the company in a research report on Wednesday, November 4th. CJS Securities assumed coverage on Transcat in a research note on Tuesday, October 27th. They set an “outperform” rating and a $115.00 target price on the stock. Northland Securities upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a report on Wednesday, October 21st. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $108.33.

Insider Activity

In related news, CEO Jaime A. Irick bought 2,275 shares of the firm’s stock in a transaction that occurred on Thursday, November 5th. The stock was purchased at an average cost of $101.26 per share, for a total transaction of $230,366.50. Following the completion of the acquisition, the chief executive officer owned 2,275 shares in the company, valued at approximately $230,366.50. This trade represents a ? increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.80% of the company’s stock.

Transcat Company Profile

Transcat, Inc. provides calibration and related services, including instrument repair, inspection and compliance support. Its services help customers maintain the accuracy and reliability of equipment used in regulated and quality-sensitive operations. The company also distributes professional-grade test, measurement and control instruments from a range of manufacturers. Its offerings include equipment used to measure and monitor variables such as pressure, temperature, electrical signals and humidity.